Herbal medicines as adjuvants for cancer therapeutics

American Journal of Chinese Medicine

Volumn 40, Issue 4, 2012, Pages 657-669

  Wang, Chong Zhi ^a,b   Calway, Tyler ^a,b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 FU; Astragalus; Botanicals; Colorectal Cancer; Compound K; Ginseng; Ginsenosides; Herb Drug Interaction; Intestinal Microbiota; Irinotecan; Metabolites; Panaxadiol; Turmeric; Valerian

Indexed keywords

ASTRAGALUS EXTRACT; CASPASE 3; CASPASE 9; CISPLATIN; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; FLUOROURACIL; GINSENG EXTRACT; GINSENOSIDE; HYPERICUM PERFORATUM EXTRACT; IRINOTECAN; KAVA; PANAXADIOL; SEDATIVE AGENT; TURMERIC; VALERIAN; WARFARIN;

AMERICAN GINSENG; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN STEM; CANCER ADJUVANT THERAPY; CHEMOPROPHYLAXIS; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONCENTRATION RESPONSE; DEGLYCOSYLATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EXCRETION; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GABAERGIC TRANSMISSION; GINSENG; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; INSOMNIA; INTESTINE FLORA; NONHUMAN; PLANT ROOT; PREMEDICATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DRUG INTERACTIONS; HERBAL MEDICINE; HUMANS; INTESTINES; NAUSEA; NEOPLASMS; VOMITING;

EID: 84864253312     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500498     Document Type: Article

References (65)

1. Almeida, J.C. and E.W. Grimsley. Coma from the health food store: Interaction between kava and alprazolam. Ann. Intern. Med. 125: 940-941, 1996.
2. Al-Suhaimi, E.A., N.A. Al-Riziza and R.A. Al-Essa. Physiological and therapeutical roles of ginger and turmeric on endocrine functions. Am. J. Chin. Med. 39: 215-231, 2011.
3. Attele, A.S., J.A. Wu and C.S. Yuan. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693, 1999. (Pubitemid 29505408)
4. Aung, H.H., L. Dey, S. Mehendale, J.T. Xie, J.A. Wu and C.S. Yuan. Scutellaria baicalensis extract decreases cisplatin-induced pica in rats. Cancer Chemother. Pharmacol. 52: 453-458, 2003. (Pubitemid 37491634)
5. Aung, H.H., S.R. Mehendale, C.Z. Wang, J.T. Xie, E. McEntee and C.S. Yuan. Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemother. Pharmacol. 59: 369-374, 2007. (Pubitemid 46025524)
6. Barnes, P.M., E. Powell-Griner, K. McFann and R.L. Nahin. Complementary and alternative medicine use among adults: United States, 2002. Adv. Data 1-19, 2004.
7. Bush, T.M., K.S. Rayburn, S.W. Holloway, D.S. Sanchez-Yamamoto, B.L. Allen, T. Lam, B.K. So, H. Tran de, E.R. Greyber, S. Kantor and L.W. Roth. Adverse interactions between herbal and dietary substances and prescription medications: A clinical survey. Altern. Ther. Health Med. 13: 30-35, 2007. (Pubitemid 46427630)
8. Chan, P.C., J.C. Peckham, D.E. Malarkey, G.E. Kissling, G.S. Travlos and P.P. Fu. Two-year toxicity and carcinogenicity studies of Panax ginseng in Fischer 344 rats and B6C3F1 mice. Am. J. Chin. Med. 39: 779-788, 2011.
9. Corbit, R., S. Ebbs, M.L. King and L.L. Murphy. The influence of lead and arsenite on the inhibition of human breast cancer MCF-7 cell proliferation by American ginseng root (Panax quinquefolius L.). Life Sci. 78: 1336-1340, 2006. (Pubitemid 43204337)
10. Cunningham, D., J. Maroun, U. Vanhoefer and E. Van Cutsem. Optimizing the use of irinotecan in colorectal cancer. Oncologist 6(Suppl 4): 17-23, 2001. (Pubitemid 32954217)
11. Dougherty, U., R. Mustafi, Y. Wang, M.W. Musch, C.Z. Wang, V.J. Konda, A. Kulkarni, J. Hart, G. Dawson, K.E. Kim, C.S. Yuan, E.B. Chang and M. Bissonnette. American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: Role of EGFR. BMC Complement. Altern. Med. 11: 111, 2011.
12. Du, G.J., C.Z. Wang, Z.Y. Zhang, X.D. Wen, J. Somogyi, T. Calway, T.C. He, W. Du and C.S. Yuan. Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells. J. Pharm. Pharmacol. 64: 727-734, 2012.
13. Ernst, E. Second thoughts about safety of St John's wort. Lancet 354: 2014-2016, 1999.
14. Ernst, E. The role of complementary and alternative medicine in cancer. Lancet Oncol. 1: 176-180, 2000.
15. Fishbein, A.B., C.Z. Wang, X.L. Li, S.R. Mehendale, S. Sun, H.H. Aung and C.S. Yuan. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: Comparison between white and red ginseng. Arch. Pharm. Res. 32: 505-513, 2009.
16. Garges, H.P., I. Varia and P.M. Doraiswamy. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 280: 1566-1567, 1998. (Pubitemid 28520640)
17. Haniadka, R., S. Popouri, P.L. Palatty, R. Arora and M.S. Baliga. Medicinal plants as antiemetics in the treatment of cancer: A review. Integr. Cancer Ther. 2011 Aug 5 [Epub ahead of print].
18. Hasegawa, H., J.H. Sung, S. Matsumiya and M. Uchiyama. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62: 453-457, 1996. (Pubitemid 26370341)
19. Houghton, P.J. The scientific basis for the reputed activity of Valerian. J. Pharm. Pharmacol. 51: 505-512, 1999. (Pubitemid 29319774)
20. Jamieson, D.D., P.H. Duffield, D. Cheng and A.M. Duffield. Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch. Int. Pharmacodyn. Ther. 301: 66-80, 1989. (Pubitemid 20055378)
21. Jang, H.I. and H.M. Shin. Wild Panax ginseng (Panax ginseng C.A. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am. J. Chin. Med. 38: 949-960, 2010.
22. Jung, H.L., H.E. Kwak, S.S. Kim, Y.C. Kim, C.D. Lee, H.K. Byurn and H.Y. Kang. Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans. Am. J. Chin. Med. 39: 441-450, 2011.
23. Kaminsky, L.S. and Z.Y. Zhang. Human P450 metabolism of warfarin. Pharmacol. Ther. 73: 67-74, 1997. (Pubitemid 26425815)
24. Kennedy, D.A. and D. Seely. Clinically based evidence of drug-herb interactions: A systematic review. Expert Opin. Drug Saf. 9: 79-124, 2010
25. Kim, Y., M.W. Park, H.D. Yuan, H.J. Lee, S.H. Kim and S.H. Chung. Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J. Agric. Food Chem. 57: 10573-10578, 2009.
26. Lee, J., E. Lee, D. Kim, J. Yoo and B. Koh. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol. 122: 143-148, 2009.
27. Li, X.L., C.Z. Wang, S.R. Mehendale, S. Sun, Q. Wang and C.S. Yuan. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother. Pharmacol. 64: 1097-1104, 2009
28. Li, X.L., C.Z. Wang, S. Sun, S.R. Mehendale, W. Du, T.C. He and C.S. Yuan. American ginseng berry enhances chemopreventive effect of 5-FU on human colorectal cancer cells. Oncol. Rep.22: 943-952, 2009b.
29. Liao, H.F., M.C. Lu, H.C. Chang, C.C. Wei, C.H. Kao, Z.H. Chen, C.C. Huang and C. Li. Effects of herbal medicinal formulas on suppressing viral replication and modulating immune responses. Am. J. Chin. Med. 38: 173-190, 2010.
30. Ma, H., J. Sullivan-Halley, A.W. Smith, M.L. Neuhouser, C.M. Alfano, K. Meeske, S.M. George, A. McTiernan, R. McKean-Cowdin, K.B. Baumgartner, R. Ballard-Barbash and L. Bernstein. Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: A HEAL study report. BMC Complement. Altern. Med. 11: 109, 2011.
31. Mehendale, S., H. Aung, A. Wang, J.J. Yin, C.Z. Wang, J.T. Xie and C.S. Yuan. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemother. Pharmacol. 56: 63-69, 2005. (Pubitemid 41201757)
32. Ortiz, J.G., J. Nieves-Natal and P. Chavez. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem. Res. 24: 1373-1378, 1999.
33. Ott, M.J. Complementary and alternative therapies in cancer symptom management. Cancer Pract. 10: 162-166, 2002. (Pubitemid 34438460)
34. Pao, L.H., O.Y. Hu, H.Y. Fan, C.C. Lin, L.C. Liu and P.W. Huang. Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo. Am. J. Chin. Med. 40: 57-73, 2012.
35. Pinedo, H.M. and G.F. Peters. Fluorouracil: Biochemistry and pharmacology. J. Clin. Oncol. 6: 1653-1664, 1988.
36. Qi, F., A. Li, Y. Inagaki, J. Gao, J. Li, N. Kokudo, X.K. Li and W. Tang. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci. Trends 4: 297-307, 2010.
37. Qi, L.W., C.Z. Wang and C.S. Yuan. Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry 72: 689-699, 2011a.
38. Qi, L.W., C.Z. Wang and C.S. Yuan. Isolation and analysis of ginseng: Advances and challenges. Nat. Prod. Rep. 28: 467-495, 2011b
39. Randhawa, M.A. and M.S. Alghamdi. Anticancer activity of Nigella sativa (black seed) - a review. Am. J. Chin. Med. 39: 1075-1091, 2011.
40. Santos, F.M., A.O. Latorre, I.M. Hueza, D.S. Sanches, L.L. Lippi, D.R. Gardner and H.S. Spinosa. Increased antitumor efficacy by the combined administration of swainsonine and cisplatin in vivo. Phytomedicine 18: 1096-1101, 2011.
41. Shumay, D.M., G. Maskarinec, H. Kakai and C.C. Gotay. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J. Fam. Pract. 50: 1067, 2001.
42. Siegel, R., D. Naishadham and A. Jemal. Cancer statistics, 2012. CA Cancer J. Clin. 62: 10-29, 2012.
43. Smorenburg, C.H., G.J. Peters, C.J. van Groeningen, P. Noordhuis, K. Smid, A.M. van Riel, W. Dercksen, H.M. Pinedo and G. Giaccone. Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase. Ann. Oncol. 17: 35-42, 2006. (Pubitemid 43033837)
44. Taira, S., R. Ikeda, N. Yokota, I. Osaka, M. Sakamoto, M. Kato and Y. Sahashi. Mass spectrometric imaging of ginsenosides localization in Panax ginseng root. Am. J. Chin. Med. 38: 485-493, 2010.
45. Tian, J.H., L.S. Liu, Z.M. Shi, Z.Y. Zhou and L. Wang. A randomized controlled pilot trial of "Feiji Recipe" on quality of life of non-small cell lung cancer patients. Am. J. Chin. Med. 38: 15-25, 2010.
46. Van Cutsem, E., L. Dirix, J.L. Van Laethem, S. Van Belle, M. Borner, M. Gonzalez Baron, A. Roth, R. Morant, E. Joosens, G. Gruia, D. Sibaud and H. Bleiberg. Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: Results from a multinational, randomised phase II study. Br. J. Cancer 92: 1055-1062, 2005. (Pubitemid 40546669)
47. Vanhoefer, U., A. Harstrick, W. Achterrath, S. Cao, S. Seeber and Y.M. Rustum. Irinotecan in the treatment of colorectal cancer: Clinical overview. J. Clin. Oncol. 19: 1501-1518, 2001. (Pubitemid 32202559)
48. Wang, C.Z., H.H. Aung, M. Ni, J.A. Wu, R. Tong, S. Wicks, T.C. He and C.S. Yuan. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 73: 669-674, 2007. (Pubitemid 47066161)
49. Wang, C.Z., G.J. Du, Z. Zhang, X.D. Wen, T. Calway, Z. Zhen, M.W. Musch, M. Bissonnette, E.B. Chang and C.S. Yuan. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int. J. Oncol. 40: 1970-1976, 2012.
50. Wang, C.Z., A. Fishbein, H.H. Aung, S.R. Mehendale, W.T. Chang, J.T. Xie, J. Li and C.S. Yuan. Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. J. Altern. Complement. Med. 11: 1059-1065, 2005. (Pubitemid 43134055)
51. Wang, C.Z., K.E. Kim, G.J. Du, L.W. Qi, X.D. Wen, P. Li, B.A. Bauer, M.B. Bissonnette, M.W. Musch, E.B. Chang and C.S. Yuan. Ultra-performance liquid chromatography and timeof- flight mass spectrometry analysis of ginsenoside metabolites in human plasma. Am. J. Chin. Med. 39: 1161-1171, 2011a.
52. Wang, C.Z., S.R. Mehendale, T. Calway and C.S. Yuan. Botanical flavonoids on coronary heart disease. Am. J. Chin. Med. 39: 661-671, 2011b.
53. Wang, C.Z., J.A. Wu, E. McEntee and C.S. Yuan. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J. Agric. Food Chem. 54: 2261-2266, 2006a.
54. Wang, C.Z., B. Zhang, W.X. Song, A. Wang, M. Ni, X. Luo, H.H. Aung, J.T. Xie, R. Tong, T.C. He and C.S. Yuan. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J. Agric. Food Chem. 54: 9936-9942, 2006b. (Pubitemid 46158993)
55. Wang, H.Y., L.W. Qi, C.Z. Wang and P. Li. Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am. J. Chin. Med. 39: 1103-1115, 2011c.
56. Wang, Y., H. Xie and S.L. Pan. Pharmacokinetics of laetispicine and its brain distribution in rats. Am. J. Chin. Med. 38: 895-907, 2010.
57. Xu, Z., X. Chen, Z. Zhong, L. Chen and Y. Wang. Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. Am. J. Chin. Med. 39: 15-27, 2011.
58. Yamaguchi, Y., E. Miyahara and J. Hihara. Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: A pilot study. Am. J. Chin. Med. 39: 451-459, 2011.
59. Yang, A.K., S.M. He, L. Liu, J.P. Liu, M.Q. Wei and S.F. Zhou. Herbal interactions with anticancer drugs: Mechanistic and clinical considerations. Curr. Med. Chem. 17: 1635-1678, 2010.
60. Yeung, K.S., J. Gubili and B. Cassileth. Evidence-based botanical research: Applications and challenges. Hematol. Oncol. Clin. North Am. 22: 661-670, 2008. (Pubitemid 351973320)
61. Yuan, C.S., L. Dey, A. Wang, S. Mehendale, J.T. Xie, H.H. Aung and M.K. Ang-Lee. Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation. Planta Med. 68: 1092-1096, 2002. (Pubitemid 36140314)
62. Yuan, C.S., S. Mehendale, Y. Xiao, H.H. Aung, J.T. Xie and M.K. Ang-Lee. The gammaaminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth. Analg. 98: 353-358, 2004a. (Pubitemid 38129379)
63. Yuan, C.S., G. Wei, L. Dey, T. Karrison, L. Nahlik, S. Maleckar, K. Kasza, M. Ang-Lee and J. Moss. American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled Trial. Ann. Intern. Med. 141: 23-27, 2004b.
64. Yun, T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat. Res. 523-524: 63-74, 2003.
65. Zeng, X.X., Z.X. Bian, T.X. Wu, S.F. Fu, E. Ziea and W.T. Woon. Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: A systematic review. Am. J. Chin. Med. 39: 1061-1074, 2011.